Acidosis and growth in nonuremic renal disease

Kidney International
|October 1, 1978
PubMed

Insights

Children with type 1 renal tubular acidosis (RTA) require significant alkali therapy for sustained acidosis correction. This treatment promotes catch-up growth and normal stature in affected children.

Area of Science:

  • Pediatrics
  • Nephrology
  • Endocrinology

Background:

  • Type 1 renal tubular acidosis (RTA) is characterized by impaired renal bicarbonate reabsorption.
  • Acidosis in RTA can lead to significant growth impairment in children.
  • Optimal alkali dosage for sustained correction remains an area of investigation.

Purpose of the Study:

  • To determine the sustained efficacy of alkali therapy in correcting acidosis in children with type 1 RTA.
  • To evaluate the impact of sustained acidosis correction on growth and stature in children with type 1 RTA and growth impairment.

Main Methods:

  • Retrospective analysis of children diagnosed with type 1 RTA.
  • Administration of alkali therapy at doses ranging from 5 to 14 mEq/kg/day.
  • Monitoring of acid-base status and growth parameters.

Main Results:

  • Sustained correction of acidosis was achieved with alkali therapy doses of 5 to 14 mEq/kg/day.
  • Children with type 1 RTA and growth impairment experienced catch-up growth and attained normal stature.
  • Large alkali doses were necessary due to significant renal bicarbonate-wasting.

Conclusions:

  • Alkali therapy is effective in sustained acidosis correction in pediatric type 1 RTA.
  • Sustained acidosis correction promotes catch-up growth and normal stature attainment in affected children.
  • Further research is needed to determine the effects of acidosis correction on growth in other renal conditions.

Related Concept Videos

Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...